We are an innovative global group with operations in Israel, Australia and the Czech Republic. We focus on providing therapeutic Medical Grade Cannabis treatments to improve the quality of lives where conventional medical treatments have not been successful.
This is based on 8 years proven track record and one of the few global Medical Grade Cannabis producers that currently grows and supplies and is an industrial manufacturer of chemical free stabilised Medical Grade Cannabis products of over 3,000kg of per year.
Cann (better™) actively treats thousands of patients on a monthly basis. As well it supplies occasionally four of its competitors. It holds a superior intellectual property portfolio in the main building blocks of the MGC sector, including:
- One of the world’s richest and diversified Genetic Bank.
- Most advanced growing technologies.
- Processing know-how and a system that ensures the optimum chemical composition as well as very low depreciation rate.
- Production Know-how.
- Medical experience and knowledge.
In Australia, as well as in Israel and in the Czech Republic, we are passionate about our mission to assist patients, governments and medical practitioners and each of us is here because we believe – both individually and collectively – that we can make a difference in the lives of citizens with chronic medical conditions.
As one of the first and largest Medical Grade Cannabis licensed producers, better™ has gained cutting edge experience in growing high yields of high quality Medical Grade Cannabis.
In Australia, we are investing in clinical research as well as assisting Australians through the Special Access Scheme of the Therapeutic Goods Administration in the short term as well as our application for cultivation licenses.